All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T cell lymphoma and relapsed/refractory aggressive B cell lymphoma

Fante, M. A. and Harrer, D. C. and Felsenstein, M. and Zartner, B. and Lueke, F. and Mayer, S. and Reichle, A. and Herr, W. and Vogelhuber, M. and Heudobler, D. (2023) All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T cell lymphoma and relapsed/refractory aggressive B cell lymphoma. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Speech)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User:	Dr. Gernot Deinzer
Date Deposited:	01 Mar 2024 07:43
Last Modified:	01 Mar 2024 07:43
URI:	https://pred.uni-regensburg.de/id/eprint/59324

Actions (login required)

View Item